These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 24366754
1. Communication about ADHD and its treatment during pediatric asthma visits. Sleath B, Sulzer SH, Carpenter DM, Slota C, Gillette C, Sayner R, Davis S, Sandler A. Community Ment Health J; 2014 Feb; 50(2):185-92. PubMed ID: 24366754 [Abstract] [Full Text] [Related]
2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM, Earls MF. Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972 [Abstract] [Full Text] [Related]
3. Communication during pediatric asthma visits and self-reported asthma medication adherence. Sleath B, Carpenter DM, Slota C, Williams D, Tudor G, Yeatts K, Davis S, Ayala GX. Pediatrics; 2012 Oct; 130(4):627-33. PubMed ID: 22945409 [Abstract] [Full Text] [Related]
4. Comorbidity of asthma with ADHD. Fasmer OB, Riise T, Eagan TM, Lund A, Dilsaver SC, Hundal O, Oedegaard KJ. J Atten Disord; 2011 Oct; 15(7):564-71. PubMed ID: 20574059 [Abstract] [Full Text] [Related]
5. Provider-caregiver-child discussions about risks associated with asthma control medications: content and prevalence. Gillette C, Blalock SJ, Rao JK, Williams D, Loughlin CE, Sleath B. Pediatr Pulmonol; 2014 Aug; 49(8):727-33. PubMed ID: 24115531 [Abstract] [Full Text] [Related]
6. Youth Views on Communication About ADHD and Medication Adherence. Sleath B, Carpenter DM, Sayner R, Thomas K, Mann L, Sage A, Sulzer SH, Sandler AD. Community Ment Health J; 2017 May; 53(4):438-444. PubMed ID: 28074407 [Abstract] [Full Text] [Related]
7. The influence of comorbid asthma on the severity of symptoms in children with attention-deficit hyperactivity disorder. Borschuk AP, Rodweller C, Salorio CF. J Asthma; 2018 Jan; 55(1):66-72. PubMed ID: 28459608 [Abstract] [Full Text] [Related]
8. Impact of asthma medication and familial factors on the association between childhood asthma and attention-deficit/hyperactivity disorder: a combined twin- and register-based study: Epidemiology of Allergic Disease. Holmberg K, Lundholm C, Anckarsäter H, Larsson H, Almqvist C. Clin Exp Allergy; 2015 May; 45(5):964-973. PubMed ID: 25772649 [Abstract] [Full Text] [Related]
9. A pre-visit video/question prompt list intervention to increase youth question-asking about attention deficit hyperactivity disorder during pediatric visits. Sleath B, Beznos B, Carpenter D, Thomas K, Annis I, Tudor G, Garcia N, Adjei A, Anastopoulos A, Leslie L, Coyne I. Patient Educ Couns; 2024 Oct; 127():108320. PubMed ID: 38851012 [Abstract] [Full Text] [Related]
10. Child and caregiver involvement and shared decision-making during asthma pediatric visits. Sleath BL, Carpenter DM, Sayner R, Ayala GX, Williams D, Davis S, Tudor G, Yeatts K. J Asthma; 2011 Dec; 48(10):1022-31. PubMed ID: 22022958 [Abstract] [Full Text] [Related]
11. Physician Office Visits for Attention-deficit/Hyperactivity Disorder in Children and Adolescents Aged 4-17 Years: United States, 2012-2013. Albert M, Rui P, Ashman JJ. NCHS Data Brief; 2017 Jan; (269):1-8. PubMed ID: 28135186 [Abstract] [Full Text] [Related]
12. Attention-Deficit/Hyperactivity Disorder in 2- to 5-Year-Olds: A Primary Care Network Experience. Bannett Y, Feldman HM, Gardner RM, Blaha O, Huffman LC. Acad Pediatr; 2021 Mar; 21(2):280-287. PubMed ID: 32360494 [Abstract] [Full Text] [Related]
13. Discussions between medical providers and children/caregivers about the benefits of asthma-control medications. Gillette C, Blalock SJ, Rao JK, Williams D, Loughlin C, Sleath B. J Am Pharm Assoc (2003); 2014 Mar; 54(3):251-7. PubMed ID: 24816351 [Abstract] [Full Text] [Related]
14. Shared decision-making in pediatrics: a national perspective. Fiks AG, Localio AR, Alessandrini EA, Asch DA, Guevara JP. Pediatrics; 2010 Aug; 126(2):306-14. PubMed ID: 20624804 [Abstract] [Full Text] [Related]
15. Association of corticosteroid use and attention deficit/hyperactivity disorder in asthmatic children varies by age. Xie L, Gelfand A, Mathew MS, Atem FD, Delclos GL, Messiah SE. J Asthma; 2023 Apr; 60(4):698-707. PubMed ID: 35696551 [Abstract] [Full Text] [Related]
16. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Klassen AF, Miller A, Fine S. Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087 [Abstract] [Full Text] [Related]
17. Implementing the American Academy of Pediatrics attention-deficit/hyperactivity disorder diagnostic guidelines in primary care settings. Leslie LK, Weckerly J, Plemmons D, Landsverk J, Eastman S. Pediatrics; 2004 Jul; 114(1):129-40. PubMed ID: 15231919 [Abstract] [Full Text] [Related]
18. Factors Associated with Attention Deficit Hyperactivity Disorder Medication Use in Community Care Settings. Kamimura-Nishimura KI, Epstein JN, Froehlich TE, Peugh J, Brinkman WB, Baum R, Gardner W, Langberg JM, Lichtenstein P, Chen D, Kelleher KJ. J Pediatr; 2019 Oct; 213():155-162.e1. PubMed ID: 31300310 [Abstract] [Full Text] [Related]
19. Treatment of US Children With Attention-Deficit/Hyperactivity Disorder in the Adolescent Brain Cognitive Development Study. Olfson M, Wall MM, Wang S, Laje G, Blanco C. JAMA Netw Open; 2023 Apr 03; 6(4):e2310999. PubMed ID: 37115542 [Abstract] [Full Text] [Related]
20. Association between medication prescription for atopic diseases and attention-deficit/hyperactivity disorder. van der Schans J, Pleiter JC, de Vries TW, Schuiling-Veninga CC, Bos JH, Hoekstra PJ, Hak E. Ann Allergy Asthma Immunol; 2016 Aug 03; 117(2):186-91. PubMed ID: 27315741 [Abstract] [Full Text] [Related] Page: [Next] [New Search]